Education: 2015 - 2020 Ph.D., Oncology, Tianjin Medical University 2010 - 2015 M.D., Clinical Medicine, Tianjin Medical University Work Experience 09/2020-12/2023 Resident. 01/2024-Now Physician-in-charge, Hepatobiliary Surgery Department, Tianjin Medical University Cancer Hospital, China 12/2020-Now Lecturer, Tianjin Medical University, China Research Funding Support: 07/2022-06/2025 Principle Investigator, Tianjin Health Technology Project (TJWJ2022QN015) 01/2022-12/2024 Principle Investigator, The Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2021KJ192) 01/2022-12/2025 Co-investigator (The 4th), The National Natural Science Foundation of China (No. 82173208) 01/2024-12/2027 Co-investigator (The 2nd), The National Natural Science Foundation of China (No. 8237111911) Honor & Awards New Strategy for Individualized Diagnosis and Treatment of Liver Cancer Based on Liquid Biopsy and Histological Sequencing, Tianjin People's Government, Scientific and Technological Advancement, Ministry of Provinces Second Prize (the 4th) Membership Secretary, Tianjin Anti-Cancer Association, Hepatobiliary Specialty Committee Journal list First author and co-first author in Oncogenesis, The FASEB journal, Hepatology International, Liver Cancer, Cancer Biology & Medicine, Bioscience Trends, Cell Death Disease, International Journal of Biological Science. IF:63.5
Ministry of Provinces Second Prize
Tianjin People's Government, Scientific and Technological Advancement
New Strategy for Individualized Diagnosis and Treatment of Liver Cancer Based on Liquid Biopsy and Histological Sequencing